Slides: Rivaroxaban study points to cost savings

Candace Stuart | | Cardiovascular Business | Economics

In an analysis of a subset of patients from the U.S. and Canada from the EINSTEIN-PE trial, Brahim Bookhart, director of Health Economics and Outcomes Research at Janssen Research & Development, and colleagues reported that patients who received rivaroxaban (Xarelto) had a shorter length of stay. That translated into savings of $2,040 per patient.

They presented their results Oct. 15 at the American College of Emergency Physicians meeting in Seattle.  

EINSTEIN found rivaroxaban, an oral factor Xa inhibitor, to be noninferior to standard therapy with enoxaparin in 4,832 patients who had acute symptomatic pulmonary embolism with or without deep-vein thrombosis.

 

Candace Stuart, Contributor

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."